# Session Handoff
**Written:** 2026-03-17

## In Progress
- PR #12 open for review: `feat: M6 SPL Interactions — browser, drug info, interaction checker`
- Branch: `feature/m6-spl-interactions`

## Completed This Session
- Beta maturity promotion (alpha → beta, 10/10 evidence score)
- Branch protection enabled on main
- M6 milestone created with 3 specs
- SPL Document Browser — client, XML parser, service, handler, 22 tests
- Drug Info Card — NDC resolution, info endpoint, 11 handler tests
- Drug Interaction Checker — cross-reference algorithm, POST endpoint, 17 tests
- All routes wired in main.go (4 new endpoints under /v1)
- Lint fixes (20 errcheck) + apikey coverage tests from pre-cycle work
- Coverage: 80.4%, 0 lint issues, all tests passing
- PR #12 created

## Decisions Made
- SPL client is separate interface (SPLClient, not bolted onto DrugClient) — follows RxNorm pattern
- XML parsing uses regex, not full XML parser — SPL XML has namespace issues, regex is simpler and sufficient
- `spls-by-class` endpoint deferred (unreliable, timeouts) — only spls-by-name used
- Cross-reference uses word-boundary regex matching (case-insensitive)
- Background indexer deferred to cycle-2 (all 3 features delivered instead)

## Blockers
- None

## Next Steps
1. Review and merge PR #12
2. Cycle-2: Background indexer for pre-fetching popular drug interactions
3. E2E tests for SPL endpoints (against live cash-drugs)
4. Update PRD roadmap (M4.5 → IN_PROGRESS, rename to M6)
5. Consider Swagger/OpenAPI docs update for new endpoints
